Novartis Oncology is conducting a clinical research study to see if an investigational drug is an effective and safe treatment in people who have brain metastases from non-small cell lung cancer (cancer of the lung that has spread to the brain). The study drug is called patupilone and it belongs to a new class of agents that works by preventing the growth of cancer cells through suppression of microtubule dynamics.

If you or a family member or friend has been diagnosed with non-small cell lung cancer that has spread to the brain, and the brain disease is recurrent after different treatments such as surgery, radiotherapy, and/or chemotherapy, and would like to see if you are eligible for this clinical trial, please click on the link below to take a high-level screening questionnaire.

To view all Novartis clinical trials recruiting in the U.S., visit NovartisClinicalTrials.com